|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 5.680 SEK | -2.74% |
|
-11.25% | +184.00% |
| 11-17 | Analysguiden sees increased opportunities for Alzecure | FW |
| 11-11 | AlzeCure Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 783M 76.68M 69.84M 64.36M 58.54M 110M 7.1B 115M 311M 3.88B 288M 282M 12.17B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 783M 76.68M 69.84M 64.36M 58.54M 110M 7.1B 115M 311M 3.88B 288M 282M 12.17B | EV / Sales 2026 * |
4.51x | EV / Sales 2027 * | 3.63x |
| Free-Float |
62.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ALZCUR | Delayed | |
| AC6 | Delayed |
| 1 day | -2.74% | ||
| 1 week | -11.25% | ||
| Current month | -11.25% | ||
| 1 month | -17.92% | ||
| 3 months | -11.53% | ||
| 6 months | +307.17% | ||
| Current year | +184.00% |
| 1 week | 5.62 | 6.68 | |
| 1 month | 5.52 | 6.8 | |
| Current year | 1.3 | 8.68 | |
| 1 year | 1.3 | 8.68 | |
| 3 years | 0.81 | 8.68 | |
| 5 years | 0.81 | 8.68 | |
| 10 years | 0.81 | 12.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pontus Forsell
CTO | Chief Tech/Sci/R&D Officer | 59 | 2016-12-31 |
Johan Sandin
CEO | Chief Executive Officer | 56 | 2026-10-26 |
Birgitta Lundvik
DFI | Director of Finance/CFO | 59 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Lundberg
BRD | Director/Board Member | 73 | 2024-05-13 |
| Chairman | 73 | 2016-12-31 | |
Ragnar Linder
BRD | Director/Board Member | 73 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/26 | Buy | Chief Executive Officer | 184,914 | 0.1341% | ||
| 7/1/26 | Buy | Founder | 194,940 | 0.1414% | ||
| 6/30/26 | Buy | Chairman | 240,625 | 0.1745% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.74% | -11.25% | +187.59% | +45.27% | 76.68M | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.87B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -1.51% | -2.22% | +48.52% | +167.01% | 40B | |
| Weighted average by Cap. | -1.48% | -1.85% | +31.86% | +155.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 174M 16.99M 15.47M 14.26M 12.97M 24.33M 1.57B 25.57M 68.96M 859M 63.73M 62.39M 2.7B | 216M 21.13M 19.24M 17.73M 16.13M 30.26M 1.96B 31.8M 85.77M 1.07B 79.27M 77.6M 3.35B |
| Net income | 91.9M 9M 8.19M 7.55M 6.87M 12.89M 833M 13.54M 36.53M 455M 33.76M 33.05M 1.43B | 141M 13.8M 12.57M 11.59M 10.54M 19.77M 1.28B 20.78M 56.04M 698M 51.79M 50.7M 2.19B |
| Net Debt | - | - |
Employees
10
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | SEK 5.680 | -2.74% | 235,331 |
| 26-11-19 | SEK 5.840 | -4.26% | 232,893 |
| 26-11-18 | SEK 6.100 | -1.29% | 135,135 |
| 26-11-17 | SEK 6.180 | -3.13% | 278,385 |
| 26-11-16 | SEK 6.380 | -0.31% | 185,835 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ALZCUR Stock
Select your edition
All financial news and data tailored to specific country editions
















